Respiratory tract infections by Mycoplasma pneumoniae in children: A review of diagnostic and therapeutic measures

European Journal of Pediatrics

Volumn 160, Issue 8, 2001, Pages 483-491

  Ferwerda, Annemarie ^a   Moll, Henriëtte A ^a   De Groot, Ronald ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Laboratory diagnosis; Mycoplasma pneumoniae; Outcome; Review; Therapy

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; DIAGNOSTIC APPROACH ROUTE; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROLOGY; SYMPTOMATOLOGY;

ANTI-BACTERIAL AGENTS; CHILD; COMPLEMENT FIXATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; MACROLIDES; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 0034929185     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100775     Document Type: Article

References (132)

1. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae
2. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial
3. The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection
4. The macrolides: Erythromycin, clarithromycin, and azithromycin
5. Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics
6. Mycoplasma pneumoniae
7. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae
8. Evaluation of five commercial tests: Complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology
9. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: Comparison with mu-capture ELISA and indirect immunofluorescence
10. Rhabdomyolysis associated with infection by Mycoplasma pneumoniae: A case report
11. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction
12. Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection
13. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate
14. An explosive outbreak of Mycoplasma pneumoniae infection in a summer camp
15. Infections due to Mycoplasma pneumoniae in childhood
16. Mycoplasma pneumoniae infections
17. Diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients by polymerase chain reaction (PCR)
18. Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae antibodies
19. Use of a triplex polymerase chain reaction for the detection and differentiation of Mycoplasma pneumoniae and Mycoplasma genitalium in the presence of human DNA
20. Efficacy of clarithromycin against Mycoplasma pneumoniae
21. Fulminant Mycoplasma pneumoniae pneumonia
22. Epidemiology of M. pneumoniae infection in military recruits
23. Mycoplasma pneumoniae and second-degree heart block
24. Mycoplasma and Ureaplasma infections
25. Development of urease conjugated enzyme-linked immunosorbent assays (ELISA) for the detection of IgM and IgG antibodies against Mycoplasma pneumoniae in human sera
26. IgM anti-P1 immunoblotting. A standard for the rapid serologic diagnosis of Mycoplasma pneumoniae infection in pediatric care
27. Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection
28. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens
29. Clinical overview of typical Mycoplasma pneumoniae infections
30. Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections
31. Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction
32. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children
33. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp
34. Indirect enzyme-linked immunosorbent assay for detection of immunoglobulin G reactive with a recombinant protein expressed from the gene encoding the 116-kilodalton protein of Mycoplasma pneumoniae
35. Comparison of enzyme-linked immunosorbent assay (ELISA) and complement fixation test for detection of Mycoplasma pneumoniae antibodies
36. Mycoplasma pneumoniae infections in University of Wisconsin students
37. Evaluation of a rapid enzyme immunoassay system for serologic diagnosis of Mycoplasma pneumoniae infection
38. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: New implications from an old scenario
39. Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: A review
40. Comparison of MYCOPLASMELISA with complement fixation test for measurement of antibodies to Mycoplasma pneumoniae
41. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients
42. Long-term epidemiology of infections with Mycoplasma pneumoniae
43. Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae
44. Middle cerebral artery occlusion after recent Mycoplasma pneumoniae infection
45. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children
46. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986 1991
47. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and mu-capture IgM methods
48. Outpatient treatment of pneumonia
49. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study
50. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas
51. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR
52. Antimicrobial therapy of pneumonia in infants and children
53. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children
54. Laboratory diagnosis of Mycoplasma pneumoniae infection. 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates
55. Outbreaks of Mycoplasma pneumoniae infections in Iceland 1987 to 1997 - A ten and a half years review
56. Etiology of childhood pneumonia: Serologic results of a prospective, population-based study
57. Guillain-Barre syndrome and optic neuritis after Mycoplasma pneumoniae infection
58. Infection with Mycoplasma pneumoniae in civilians in the Netherlands
59. Application of an indirect immunofluorescence test for detection of Mycoplasma pneumoniae in respiratory exudates
60. ELISA for detection of Mycoplasma pneumoniae antigens using monoclonal antibodies
61. Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae specific immunoglobulin M
62. Clinical use of capillary PCR to diagnose Mycoplasma pneumonia
63. Demonstration of antibodies to Mycoplasma pneumoniae attachment protein in human sera and respiratory secretions
64. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients
65. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae
66. Serological diagnosis of Mycoplasma pneumoniae infections: A critical review of current procedures
67. Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting
68. Detection of Mycoplasma pneumoniae in simulated clinical samples by polymerase chain reaction. Brief report
69. Rapid detection of Mycoplasma pneumoniae in clinical samples by the polymerase chain reaction
70. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae
71. Efficacy of roxithromycin in the treatment of Mycoplasma pneumonia
72. Susceptibilities of Mycoplasma pneumoniae. Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)
73. Diagnosis of Mycoplasma pneumoniae pneumonia: Sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections
74. Rapid detection of Mycoplasma pneumoniae by an assay based on PCR and probe hybridization in a nonradioactive microwell plate format
75. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia
76. Guillain-Barre syndrome associated with IgG anti-GM1b antibody subsequent to Mycoplasma pneumoniae infection
77. Evaluation of an antigen-capture enzyme immunoassay for rapid diagnosis of Mycoplasma pneumoniae infection
78. Laboratory diagnosis of Mycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay
79. Laboratory diagnosis of Mycoplasma pneumoniae infection. 3. Detection of IgM antibodies to M. pneumoniae by a modified indirect haemagglutination test
80. Mycoplasma pneumoniae meningoencephalitis and cerebellitis with antiganglioside antibodies
81. CNS manifestations associated with Mycoplasma pneumoniae infections: Summary of cases at the University of Helsinki and review
82. Azithromycin. A review of its use in paediatric infectious diseases
83. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients
84. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods
85. Comparative studies of three serologic methods for the measurement of Mycoplasma pneumoniae antibodies
86. Bronchitis obliterans due to Mycoplasma pneumonia
87. Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature
88. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark
89. Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease
90. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995
91. Pneumonia caused by Mycoplasma pneumoniae infection
92. Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates
93. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children
94. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia
95. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use
96. Chemistry and mode of action of macrolides
97. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl
98. Bilateral optic papillitis following Mycoplasma pneumoniae pneumonia
99. Acute transverse myelitis associated with Mycoplasma pneumoniae infection: A case report and review of the literature
100. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966
101. A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia
102. The specific IgM response to Mycoplasma pneumoniae infection: Interpretation and application to early diagnosis
103. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: Diagnostic performance of a seminested 16S rDNA-PCR
104. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia
105. Bell's palsy associated with Mycoplasma pneumoniae infection
106. Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration
107. Questionable specificity of lipid antigen in the Mycoplasma pneumoniae complement fixation test in patients with extrapulmonary manifestations
108. Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay
109. Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction-based test for Mycoplasma pneumoniae
110. Pneumonia in childhood: Etiology and response to antimicrobial therapy
111. Mycoplasma pneumoniae-associated nephritis in children
112. Detection and discrimination of Mycoplasma pneumoniae and Mycoplasma genitalium by the in vitro DNA amplification
113. An outbreak of Mycoplasma pneumoniae infection in a nuclear submarine
114. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias
115. The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections
116. Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction
117. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections
118. Secondary bacterial infections in children with proved Mycoplasma pneumoniae
119. Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina
120. Mycoplasma pneumoniae infections in children
121. Infections due to species of Mycoplasma and Ureaplasma: An update
122. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum
123. Mycoplasma pneumoniae infection and neurological disease
124. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections
125. Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia
126. Current status of the mollicute flora of humans
127. Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection
128. 16S rRNA based polymerase chain reaction compared with culture and serological methods for diagnosis of Mycoplasma pneumoniae infection
129. Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae
130. Diagnosis of Mycoplasma pneumoniae pneumonia in children
131. Mycoplasma pneumoniae. Complement-fixing antibody titers at birth
132. Laboratory diagnosis of Mycoplasma pneumoniae infection. 4. Antigen capture and PCR-gene amplification for detection of the Mycoplasma: Problems of clinical correlation